US Tariff Proposal Prompts Indian Pharma to Diversify and Innovate, Experts Say

Pharmaceuticals

26 July 2026 at 3:19 pm

US Tariff Proposal Prompts Indian Pharma to Diversify and Innovate, Experts Say

HyperFast News

Summary

Experts are advising the Indian pharmaceutical industry to diversify globally and prioritize innovation in response to proposed US pharma tariffs. This strategic shift aims to reduce market reliance and ensure continued access to affordable medications.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.

FAQ

Newsroom FAQs

About the public HyperFast News news feed powered by NewsEngine.

US Tariff Proposal Prompts Indian Pharma to Diversify and Innovate, Experts Say | HyperFast